<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2018.87032</article-id><article-id pub-id-type="publisher-id">WJCD-85971</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiological and Clinical Study of Cardiac Diseases in the Pediatric Department of the University Hospital Gabriel Tour&#233; (UH GT), Bamako (Mali)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maiga</surname><given-names>Belco</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bâ</surname><given-names>Hamidou Oumar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sacko</surname><given-names>Karamoko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dembélé</surname><given-names>Adama</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sanogo</surname><given-names>Nouhoum</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cissé</surname><given-names>Mohamed Elmouloud</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Togo</surname><given-names>Pierre</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diakité</surname><given-names>Abdoul Aziz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dicko-Traoré</surname><given-names>Fatoumata</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sylla</surname><given-names>Mariam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Cardiology UH GT, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Pediatric Department UH GT, Bamako, Mali</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>bhamiba@yahoo.fr(BHO)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>07</month><year>2018</year></pub-date><volume>08</volume><issue>07</issue><fpage>328</fpage><lpage>336</lpage><history><date date-type="received"><day>2,</day>	<month>June</month>	<year>2018</year></date><date date-type="rev-recd"><day>10,</day>	<month>July</month>	<year>2018</year>	</date><date date-type="accepted"><day>13,</day>	<month>July</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction
  : Children’s heart disease is a major public health problem in developing countries and especially in Mali. The purpose of our work was to determine frequency, different types of heart disease and their short term evolution in the pediatric department. <b>Methods</b>: We performed a retrospective study among children aged 0 to 15 years, hospitalized in the pediatric department from January to December 2015 and whose diagnosis was confirmed using trans-thoracic echocardiography. <b>Results</b>: We included 103 cases of heart disease out of a total of 8613 admissions in the pediatric department, giving an hospital prevalence of 1.2%. Mean age was 4.1 years (from 1 day to 15 years) and children under 5 years were the most affected with 73.80% of cases. Male predominance was noted (sex ratio = 1.2). Respiratory distress was the most common circumstance of discovery (93.20%). Cardiac murmur and tachycardia were the most common cardiac signs with respectively 88.35% and 83.50%. Congenital heart disease accounted for 70.87% and was dominated by ventricular septal defect (VSD) with 30.13%. Acquired heart disease (29.13% of the sample) was dominated by mitral regurgitation (MR) with 56.67%. Mortality rate was 31.9% for congenital heart disease and 11.1% for acquired heart disease. <b>Conclusion</b>: children’s heart disease is responsible for high mortality. Early detection improves the management of this pathology, which remains frequent
  .
 
</p></abstract><kwd-group><kwd>Cardiac Disease</kwd><kwd> Congenital</kwd><kwd> Acquired</kwd><kwd> Pediatric</kwd><kwd> Bamako</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Pediatric heart disease represents an underestimated heavy burden in developing countries where efforts are focused mainly on the control of infectious diseases. The prevalence of congenital heart disease (CHD) is estimated at 9.1 per 1000 live births according to van der Linde et al. [<xref ref-type="bibr" rid="scirp.85971-ref1">1</xref>] and their increasing incidence in the order of 9.7, 9.9, and 11.1 per 1000 live births respectively at 1 week, 1 month and 1 year [<xref ref-type="bibr" rid="scirp.85971-ref2">2</xref>] . Although acquired heart disease (AHD), particularly rheumatic heart disease (RHD), was a global problem until the middle of the 20th century, it is now only a problem for developing countries. In addition, age-adjusted prevalence has decreased in many parts of the world, remaining high in Oceania, sub-Saharan Africa and South-East Asia [<xref ref-type="bibr" rid="scirp.85971-ref3">3</xref>] .</p><p>The prevalence of pediatric heart disease in sub-Saharan Africa is estimated to be around 8 per 1000 live births for CHD and at least 1 in 14 per 1000 RHD [<xref ref-type="bibr" rid="scirp.85971-ref4">4</xref>] . Management of these children heart diseases in the countries of sub-Saharan Africa and particularly in Mali still pose enormous difficulties of diagnosis and access to treatment, particularly surgical treatment, thus contributing to an increase in infant mortality and morbidity [<xref ref-type="bibr" rid="scirp.85971-ref5">5</xref>] . Performed studies found prevalence of 5.8% in Cameroon [<xref ref-type="bibr" rid="scirp.85971-ref6">6</xref>] , 1.5% among children in Uganda [<xref ref-type="bibr" rid="scirp.85971-ref7">7</xref>] , 21.5% in Mozambique [<xref ref-type="bibr" rid="scirp.85971-ref8">8</xref>] and 0.61% in Burkina Faso [<xref ref-type="bibr" rid="scirp.85971-ref9">9</xref>] .</p><p>In Mali, until recently, studies on heart disease were mostly clinic-based [<xref ref-type="bibr" rid="scirp.85971-ref10">10</xref>] and nowadays more and more with the contribution of echocardiography [<xref ref-type="bibr" rid="scirp.85971-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref12">12</xref>] in cardiology departments. Our study is one of the few in the pediatric community to routinely use echocardiographic diagnosis with the aim of providing more accurate data and filling the data gap in the field of pediatric heart disease publications in UH GT.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>Our study was conducted at the University Hospital Center (CHU) Gabriel Tour&#233; (GT), 3rd Reference Hospital, located in Commune III in Bamako and easily accessible to the majority of the population.</p><p>It was a retrospective study from January 1st to December 31st, 2015 on a representative sample of all children aged 0 to 15 years hospitalized in the pediatric department of UH GT for heart disease.</p><p>For acquired diseases specially rheumatic heart diseases we used the revised Jones criteria of 1992 [<xref ref-type="bibr" rid="scirp.85971-ref13">13</xref>] and all echocardiographies were performed by pediatric cardiologist. RHD was retained if a patient had:</p><p>1) history of RF (more than 3 months) or not</p><p>2) recent (less than 3 months ) or past episode of RF</p><p>3) clinical or echocardiographic finding of</p><p>- valvular heart disease (mitral regurgitation, mitral stenosis, aortic insufficiency/stenosis) compatible with rheumatic heart disease.</p><p>- myocardial involvement.</p><p>- pericardial involvement.</p><p>Inclusion was based on echocardiographic confirmation of the diagnosis. Suspected cases with no echocardiographic confirmation were not included.</p><p>We developed a survey formulary that allowed us to collect patients data from outclinic and hospitalization registers. Records on socio-demographic, clinical and echocardiographic data were collected. Data collection was realized under consideration of confidential aspects.</p><p>The data was analyzed using Microsoft Excel 2013 and Epi Info version 3.5.3. The Chi-square test was used for statistical tests, with p considered significant if less than 0.05.</p><p>The study was approved by the administration of the hospital after consideration of ethical aspects.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, among 8613 hospitalized children, we found 103 cases of heart diseases, giving an hospital prevalence of 1.2%.</p><sec id="s3_1"><title>3.1. Epidemiological Characteristics</title><p>The age group 0 - 4 years was the most represented with 73.80%, mean age was 4.11 years from 1 day to 15 years. Sex ratio was 1.2.</p><p>Patients from consanguineous marriages accounted for 19.42% and parents were largely unschooled (65.05%). An history of prematurity and a maternal risk factor were found in respectively 01.94% and 06.80% of cases (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Clinical Features</title><p>The circumstances of discovery were dominated by respiratory distress (93.20%), cyanosis (31.06%) and edema (26.21%). Fever on admission was found in 38.80% of cases. A proportion of 55.30% of patients had a failure to thrive. Heart murmur and tachycardia were the most represented cardiac signs with respectively 88.35% and 83.50%. Tachypnea was the predominant respiratory sign and found in 89.32% of cases (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>CHD were the widely found pathologies with 70.87% versus 29.13% of RHD (Diagram 1). CHD were discovered before 5 years (98.6%) and RHD after 5 years (87.3%) (<xref ref-type="table" rid="table3">Table 3</xref>) with a significant p value of 0.037.</p><p>The most common complications were hypoxic spells and cardiac failure in 13.60% and 08.74% of cases respectively (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_3"><title>3.3. Echocardiographic Features</title><p>CHD were dominated by Ventricular septal defect (VSD), atrial septal defect (ASD), Tetralogy of Fallot (TF), atrioventricular septal defect (AVSD) respectively in 30.14%, 19.18%, 12.33% and 8.22% (Diagram 2).</p><p>RHD were dominated by mitral regurgitation (MR) (56.67%), presumed myocarditis (10%) and pericarditis (6.66%) (Diagram 3).</p><disp-formula id="scirp.85971-formula5"><graphic  xlink:href="//html.scirp.org/file/2-1910771x2.png"  xlink:type="simple"/></disp-formula><p>Diagram 1. Distribution of heart disease types for 103 patients in the pediatric department of the UH GT. CHD: congenital heart disease, AHD: acquired heart disease.</p><disp-formula id="scirp.85971-formula6"><graphic  xlink:href="//html.scirp.org/file/2-1910771x3.png"  xlink:type="simple"/></disp-formula><p>Diagram 2. Distribution of CHD types for 73 diseases found in the pediatric department in the UH GT. VSD: ventricular septal defect, ASD: atrial septal defect, TF: Tetralogy of Fallot, AVSD: atrio-ventricular septal defect, TGV: Transposition of great vessels, PDA: Persistent ductus arteriosus, DCMP: dilated cardiomyopathy, SV: single ventricle, PA + VSD: pulmonary atresia + VSD.</p><disp-formula id="scirp.85971-formula7"><graphic  xlink:href="//html.scirp.org/file/2-1910771x4.png"  xlink:type="simple"/></disp-formula><p>Diagram 3. Distribution of AHD types for 30 cases in the pediatric department of the UH GT. MR: mitral regurgitation, AR: aortic regurgitation, DCMP: dilated Cardiomyopathy.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of socio-demographics and history of 103 hospitalized patients in the pediatric department of UH GT</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Characteristics</th><th align="center" valign="middle" >Proportion N (%)</th></tr></thead><tr><td align="center" valign="middle" >Age group (years)</td><td align="center" valign="middle" >0 - 4</td><td align="center" valign="middle" >76 (73.80)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >5 - 9</td><td align="center" valign="middle" >12 (11.65)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >10 - 15</td><td align="center" valign="middle" >15 (14.55)</td></tr><tr><td align="center" valign="middle" >Mother instruction level</td><td align="center" valign="middle" >Unschooled</td><td align="center" valign="middle" >78 (75.70)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >13 (12.60)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >09 (08.80)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >03 (02.90)</td></tr><tr><td align="center" valign="middle" >Father instruction level</td><td align="center" valign="middle" >Unschooled</td><td align="center" valign="middle" >67 (65.05)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >14 (13.60)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >12 (11.65)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >10 (09.70)</td></tr><tr><td align="center" valign="middle" >Vaccination</td><td align="center" valign="middle" >Complete</td><td align="center" valign="middle" >63 (61.16)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Incomplete</td><td align="center" valign="middle" >20 (19.42)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Any</td><td align="center" valign="middle" >14 (13.60)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >NA*</td><td align="center" valign="middle" >06 (05.82)</td></tr><tr><td align="center" valign="middle" >Prenatal visit investigations</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >75 (72.80)</td></tr><tr><td align="center" valign="middle" >consanguineous parents</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >20 (19.42)</td></tr><tr><td align="center" valign="middle" >Maternal risk factor**</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >07 (06.80)</td></tr><tr><td align="center" valign="middle" >History</td><td align="center" valign="middle" >Prematurity</td><td align="center" valign="middle" >02 (01.94)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Repeated throat angina</td><td align="center" valign="middle" >08 (07.77)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >recurrent broncho-pulmonary infections</td><td align="center" valign="middle" >71 (68.93)</td></tr></tbody></table></table-wrap><p>NA* No answer ** Hypertension (4), Diabetes (1), alcohol consumption (2).</p><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Clinical characteristics of 103 patients with heart diseases in pediatric department of the UH GT</title></caption><table-wrap id="2_1"><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >Proportion N (%)</th></tr></thead><tr><td align="center" valign="middle" >circumstances of discovery</td><td align="center" valign="middle" >Respiratory distress</td><td align="center" valign="middle" >96 (93.20)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Edema</td><td align="center" valign="middle" >27 (26.21)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cyanosis</td><td align="center" valign="middle" >32 (31.06)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Thorax deformation</td><td align="center" valign="middle" >18 (17.47)</td></tr><tr><td align="center" valign="middle" >Fever on admission</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >40 (38.80)</td></tr><tr><td align="center" valign="middle" >Cardiac signs</td><td align="center" valign="middle" >Tachycardie</td><td align="center" valign="middle" >86 (83.50)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bradycardie</td><td align="center" valign="middle" >03 (02.90)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Murmur</td><td align="center" valign="middle" >91 (88.35)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Galop</td><td align="center" valign="middle" >17 (16.50)</td></tr><tr><td align="center" valign="middle" >Respiratory signs</td><td align="center" valign="middle" >Rales</td><td align="center" valign="middle" >74 (71.84)</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Tachypnea</th><th align="center" valign="middle" >92 (89.32)</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bradypnea</td><td align="center" valign="middle" >05 (04.85)</td></tr><tr><td align="center" valign="middle" >Failure to thrive</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >57 (55.30)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >46 (44.70)</td></tr><tr><td align="center" valign="middle" >Saturation</td><td align="center" valign="middle" >&lt;95%</td><td align="center" valign="middle" >61 (59.22)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >&gt;95%</td><td align="center" valign="middle" >28 (27.18)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not available</td><td align="center" valign="middle" >14 (13.60)</td></tr><tr><td align="center" valign="middle" >Complications</td><td align="center" valign="middle" >Hypoxic spells</td><td align="center" valign="middle" >14 (13.60)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Heart failure</td><td align="center" valign="middle" >09 (08.74)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Stroke</td><td align="center" valign="middle" >02 (01.94)</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of heart disease type related to age group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age group (years)</th><th align="center" valign="middle"  colspan="2"  >CHD</th><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >AHD</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >0 - 4</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >98.6</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >13.3</td></tr><tr><td align="center" valign="middle" >5 - 9</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >00.0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >40.0</td></tr><tr><td align="center" valign="middle" >10 - 14</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.4</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >46.7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap></sec><sec id="s3_4"><title>3.4. Outcome</title><p>Mortality was higher among CHD with 31% versus 11% of RHD patients during the hospitalization period (p = 0.037) (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Our study shows a significant prevalence of 1.2% in pediatric heart disease in the pediatric department of UH GT. Ellena M. et al. [<xref ref-type="bibr" rid="scirp.85971-ref14">14</xref>] found 1.7% of cases whereas Ba et al. [<xref ref-type="bibr" rid="scirp.85971-ref15">15</xref>] reported a very low prevalence 4.3/1000.</p><p>The 0 to 4 age group was the most affected (73.80%) with a mean age of 4.11 years. Diarra B. [<xref ref-type="bibr" rid="scirp.85971-ref16">16</xref>] had recorded 57.33% of patients aged between 10 and 15 years. This difference could be explained by the high prevalence of rheumatic heart disease in his study.</p><p>In our study, 103 cases of heart disease were identified by echocardiography, and CHD was much more common (70.87%) than AHD (29.13%). The same results were reported by several African publications [<xref ref-type="bibr" rid="scirp.85971-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref18">18</xref>] . The vast majority of CHD cases (98.6%) were diagnosed before the age of 5. Tougouma SJB [<xref ref-type="bibr" rid="scirp.85971-ref9">9</xref>] , Kinda G [<xref ref-type="bibr" rid="scirp.85971-ref19">19</xref>] in Ouagadougou, Cloarec [<xref ref-type="bibr" rid="scirp.85971-ref20">20</xref>] in France, and Abena [<xref ref-type="bibr" rid="scirp.85971-ref21">21</xref>] recorded lower rates with respectively 53%, 03%, 55%, 61% and 70%. The delay in the discovery and management of cardiac diseases in general and CHD in particularly could be partly explained by the absence of systematic screening at birth, difficulties in accessing echocardiographic examination and also to the</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Outcome of 96 patients with heart diseases in the study period in the pediatric department</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of heart disease</th><th align="center" valign="middle" >Living</th><th align="center" valign="middle" >Dead</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >CHD</td><td align="center" valign="middle" >47 (69%)</td><td align="center" valign="middle" >22 (31%)</td><td align="center" valign="middle" >69</td></tr><tr><td align="center" valign="middle" >AHD</td><td align="center" valign="middle" >24 (88.9%)</td><td align="center" valign="middle" >03 (11.1%)</td><td align="center" valign="middle" >27</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >96</td></tr></tbody></table></table-wrap><p>p = 0.037, Nota Bene: 5 cases of CHD and 2 of AHD were considered lost.</p><p>presence of certain forms that are not very symptomatic and may go unnoticed on clinical examination.</p><p>About AHD, 86.66% were discovered after the fifth year of life, as found by other [<xref ref-type="bibr" rid="scirp.85971-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref23">23</xref>] . This could be explained by the long latency period required for development of post-rheumatic complications.</p><p>The most current CHD in our study was isolated VSD with 30.13% as found several African authors [<xref ref-type="bibr" rid="scirp.85971-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref25">25</xref>] .</p><p>Isolated MR with 56.67% of cases was the most common AHD. This was the same finding in other African studies [<xref ref-type="bibr" rid="scirp.85971-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.85971-ref22">22</xref>] .</p><p>We recorded 31.90% of deaths among CHD patients and 11.10% among those with AHD. Ba et al. [<xref ref-type="bibr" rid="scirp.85971-ref15">15</xref>] recorded 24.4% overall lethality. In contrast, Bitwe MR et al. [<xref ref-type="bibr" rid="scirp.85971-ref24">24</xref>] had death rates higher than ours with 34.29%. Some of our unpublished data from Thesis for medical student, found 45.09% of deaths but in pediatric resuscitation unit. These deaths are most often due to a delay in diagnosis and/or the management of complications such as hypoxic spells, heart failure, broncho-pulmonary diseases. Moreover the lack of human resources, material and/or financial issues is contributing factors to the poor outcome of heart diseases specially in children age. These issues had been already underlined by Ba [<xref ref-type="bibr" rid="scirp.85971-ref11">11</xref>] and Diarra [<xref ref-type="bibr" rid="scirp.85971-ref26">26</xref>] .</p><p>There is some progress related to management of diseases such ductus closure, pulmonary blood supply through external conduit, but open-heart surgery is up to day not possible in Mali, contribution to the high mortality of pediatric heart diseases.</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study, although containing some limitations, shows that children heart diseases are frequent, CHD more represented than AHD. We had a similar pattern than in other countries but higher mortality rate. There is also urgent need to focus on the early detection of childhood heart disease and improve their access to cardiac surgery.</p></sec><sec id="s6"><title>Limits of the Study</title><p>This was a retrospective study that has the disadvantage of not providing all the desired data. Otherwise, neonates with severe CHD who died shortly after birth, patients who did not receive Doppler ultrasound and those who could not access the hospital were not included.</p><p>We had only echocardiography as investigation tool for confirmation. Other diagnostic tool, namely the cardiac catheter and magnetic resonance imaging that could have provided an accurate diagnosis or limited false negatives, are not available.</p></sec><sec id="s7"><title>Cite this paper</title><p>Belco, M., Oumar, B.H., Karamoko, S., Adama, D., Nouhoum, S., Elmouloud, C.M., Pierre, T., Aziz, D.A., Fatoumata, D.-T. and Mariam, S. (2018) Epidemiological and Clinical Study of Cardiac Diseases in the Pediatric Department of the University Hospital Gabriel Tour&#233; (UH GT), Bamako (Mali). World Journal of Cardiovascular Diseases, 8, 328-336. https://doi.org/10.4236/wjcd.2018.87032</p></sec></body><back><ref-list><title>References</title><ref id="scirp.85971-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Van der Linde, D., Konings, E.E., Slager, M.A., et al. (2011) Birth Prevalence of Congenital Heart Disease Worldwide: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology, 58, 2241-2247.  
https://doi.org/10.1016/j.jacc.2011.08.025</mixed-citation></ref><ref id="scirp.85971-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Qu, Y., Liu, X., Zhuang, J., et al. (2016) Incidence of Congenital Heart Disease: The 9-Year Experience of the Guangdong Registry of Congenital Heart Disease, China. PloS One, 11, 0159257. https://doi.org/10.1371/journal.pone.0159257</mixed-citation></ref><ref id="scirp.85971-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Watkins, D.A., Johnson, C.O., Colquhoun, S.M., et al. (2017) Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. The New England Journal of Medicine, 377, 713-722. https://doi.org/10.1056/NEJMoa1603693</mixed-citation></ref><ref id="scirp.85971-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Zuhlke, L., Mirabel, M., et al. (2013) Congenital Heart Disease and Rheumatic Heart Disease in Africa: Recent Advances and Currents Priorities. Heart, 99, 1554-1561.  
https://doi.org/10.1136/heartjnl-2013-303896</mixed-citation></ref><ref id="scirp.85971-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mocumbi, A.O., Lameira, E., Yaksh, A., et al. (2011) Challenges on the Management of Congenital Heart Disease in Developing Countries. International Journal of Cardiology, 148, 285-288. https://doi.org/10.1016/j.ijcard.2009.11.006</mixed-citation></ref><ref id="scirp.85971-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Nkoke, C., Lekoulou, A., Dzudie, A., et al. (2016) Echocardiographic Pattern of Rheumatic Valvular Disease in a Contemporary Sub-Saharan African Pediatric Population: An Audit of a Major Cardiac Ultrasound Unit in Yaounde, Cameroon. BMC Pediatrics, 16, 43. https://doi.org/10.1186/s12887-016-0584-z</mixed-citation></ref><ref id="scirp.85971-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Beaton, A., Okello, E., Lwabi, P., et al. (2012) Echocardiography Screening for Rheumatic Heart Disease in Ugandan Schoolchildren. Circulation, 125, 3127-3132.  
https://doi.org/10.1161/CIRCULATIONAHA.112.092312</mixed-citation></ref><ref id="scirp.85971-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Marijon, E., Ou, P., Celermajer, D., et al. (2007) Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. The New England Journal of Medicine, 357, 470-476. https://doi.org/10.1056/NEJMoa065085</mixed-citation></ref><ref id="scirp.85971-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Tougouma, S.J.-B., Kissou, S.-L.A., Yaméogo, A.A., et al. (2016) Les cardiopathies de l’enfant au CHU Souro Sanou de Bobo-Dioulasso: aspects échocardiographies et thérapeutiques. The Pan African Medical Journal, 25, 62.  
https://doi.org/10.11604/pamj.2016.25.62.9508</mixed-citation></ref><ref id="scirp.85971-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, B. and Touré, M.K. (1994) Etude épidémiologique, clinique et évolutive de 96 cas de valvulopathies rhumatismales. Cardiologie Tropicale, 20, 121-124.</mixed-citation></ref><ref id="scirp.85971-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">BA, H.O., Maiga, A.K., Daffé, S., et al. (2013) Aspects épidémiologiques et cliniques des cardiopathies infanto-juvéniles Ann. Annales De Chirurgie Thoracique Et Cardio-Vasculaire, 8, 77-81.</mixed-citation></ref><ref id="scirp.85971-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Menta, I., Ba, H.O., Dimazoré, S., et al. (2015) Etude descriptive de la CIV au centre hospitalier Mère-Enfant Le Luxembourg. Mali Médical, Tome XXX, N°1.</mixed-citation></ref><ref id="scirp.85971-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">American Heart Association, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association (1992) Guidelines for the Diagnosis of Rheumatic Fever: Jones Criteria. JAMA, 268, 2069-2073. https://doi.org/10.1001/jama.1992.03490150121036</mixed-citation></ref><ref id="scirp.85971-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Mbolla, E.,Oko, A., Okoko, A.R., et al. (2014) Pronostic immédiat des cardiopathies prises en charge chez les enfants de moins de 15 ans dans le service des soins intensifs pédiatriques du CHU de Brazzaville de Janvier à Décembre 2011. Médecine et Santé Tropicales, 2, 204-207.</mixed-citation></ref><ref id="scirp.85971-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ba Ngouala, G.A.B., Affangla, D.A., Leye, M., et al. (2015) Prevalence des cardiopathies infantiles symptomatiques au Centre Hospitalier Régional de Louga, Senegal. Cardiovascular Journal of Africa, 26, e1-e5.  
https://doi.org/10.5830/CVJA-2015-031</mixed-citation></ref><ref id="scirp.85971-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, B. (2018) Cardiopathies juvéniles opérées et/ou opérables du service de cardiologie de l’hopital Gabriel TOURE à propos de 268 cas. Thèse Méd., Mali-Bamako02M96.  
http://www.keneya.net/fmpos/theses/2002/med/pdf/02M96.pdf</mixed-citation></ref><ref id="scirp.85971-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kane</surname><given-names> F.B. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Etude préliminaire des cardiopathies chez l’enfant Mauritanien</article-title><source> Médecine d’Afrique Noire</source><volume> 47</volume>,<fpage> 492</fpage>-<lpage>493</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.85971-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Diby, K.F., Azagoh, R., N’goran, Y., et al. (2010) Etiologies des syndromes infectieux au cours des cardiopathies congénitales et acquises de l’enfant. Annales Africaines de Chirurgie Thoracique et Cardiovasculaire, 5, 77-81.</mixed-citation></ref><ref id="scirp.85971-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Kinda, G., Millogo, G.R.C., Koueta, F., et al. (2015) Cardiopathies aspects epidemiologiques et echographiques à propos de 109 cas au centre hospitalier universitair/Google Scholare pédiatrique Charles de Gaulle(CHUP-CDG) de ouagadougou, Burkina Faso. Pan African Medical Journal, 20, 81.</mixed-citation></ref><ref id="scirp.85971-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Cloarec, S., Magontier, N., Vaillant, M.C., et al. (1999) Prevalence et repartition des cardiopathies congenitales Indre et Loire évaluation du diagnostic anténatal: 1991-1994. Archives de Pédiatrie, 6, 1059-1065.  
https://doi.org/10.1016/S0929-693X(00)86979-1</mixed-citation></ref><ref id="scirp.85971-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Abena-Obama, M.T., Muna, W.F.T., Lekpa, J.P., et al. (1995) Cardio Vascular Discorders in Sub-Saharan African Children a Hospital Based Experience in Cameroon. Cardiologie Tropicale, 21, 5-11.</mixed-citation></ref><ref id="scirp.85971-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Moyen, G., Okoko, A., MbiKa, A., et al. (1999) Rhumatisme articulaire aigu et cardiopathies rhumatismales de l’enfant à Brazzaville. Médecine d’Afrique Noire, 46, 258-263.</mixed-citation></ref><ref id="scirp.85971-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Kombila, P. and Mounanga, N. (1986) Valvulopathies à Libreville, résultats opératoires à 5 ans. Médecine d’Afrique Noire, 36, 475-479.</mixed-citation></ref><ref id="scirp.85971-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bitwe, M.R. and Nduwayo, A. (2015) Dhembu. Les difficultés de la prise en charge des cardiopathies congénitales et leurs conséquences sur l’évolution des patients. Revue médicale des Grands Lacs, 14, 293-305.</mixed-citation></ref><ref id="scirp.85971-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Diakité, A., Sidibé, N., Diarra, M.B., et al. (2009) Aspects épidémiologiques et cliniques des cardiopathies congénitales Mali Médical, 24, 67-68.</mixed-citation></ref><ref id="scirp.85971-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M.B., Ba, H.O., Sanogo, K.M., et al. (2006) Le cout des évacuations cardiovasculaires et les besoins en traitement chirurgical et interventionnel au Mali. Cardiologie Tropicale, 32, 66-68.</mixed-citation></ref></ref-list></back></article>